Placebo-controlled, randomized clinical trial with repeated liver biopsies: Long-term resveratrol treatment has no clear therapeutic benefit in non-alcoholic fatty liver disease
Ontology highlight
ABSTRACT: Resveratrol treatment has shown beneficial effects on experimental models of non-alcoholic liver disease (NAFLD). In this pilot-size, clinical trial we teated the therapeutic potential in NAFLD patients. We found only limited clinical effect of resveratrol treatment.
ORGANISM(S): Homo sapiens
PROVIDER: GSE68421 | GEO | 2016/04/30
SECONDARY ACCESSION(S): PRJNA282686
REPOSITORIES: GEO
ACCESS DATA